| PACMEL |
Advanced BRAF-wild-type melanoma |
Paclitaxel with or without GSK1120212 |
II |
|
| Tesetaxel |
Advanced melanoma (not ocular/mucosal) |
Tesetaxel monotherapy, open label, single arm |
II |
|
| Pazopanib and paclitaxel |
Advanced melanoma, first line |
Pazopanib and paclitaxel, open label, single arm |
II |
|
| ADI-PEG 20 plus cisplatin |
Advanced melanoma |
ADI-PEG 20 plus cisplatin, open label, single arm |
I |
|
| Carboplatin, paclitaxel and bevacizumab ± everolimus |
Metastatic melanoma |
Carboplatin, paclitaxel and bevacizumab ± everolimus, open label |
II |
|
| Nab-paclitaxel plus ipilimumab |
Advanced melanoma |
Nab-paclitaxel plus ipilumumab, single arm |
II |
|
| Decitabine, temozolomide and panobinostat |
Metastatic melanoma |
Decitabine, temozolomide and panobinostat, single arm |
I/II |
